Patients With Tourette Syndrome Susceptible to Assault, Committing Crimes
Researchers sought to establish whether patients with Tourette syndrome or chronic tic disorder are more likely to experience violent assault or be convicted of a crime.
Researchers sought to establish whether patients with Tourette syndrome or chronic tic disorder are more likely to experience violent assault or be convicted of a crime.
Individuals with Tourette syndrome (TS) or chronic tic disorder (CTD) have a higher risk for both experiencing violent assault and being perpetrators of violence..
Investigators examined whether deutetrabenazine dosing is a safe and effective treatment for tics associated with Tourette syndrome in the pediatric and adolescent population.
The Food and Drug Administration (FDA) has granted Fast Track designation to ecopipam (Emalex Biosciences), an investigational agent for the treatment of Tourette syndrome (TS).
An expert subcommittee of the AAN has released an updated evidence-based clinical practice guideline on treating Tourette syndrome and other chronic tic disorders.
Antipsychotics have been shown to reduce tic severity, as has behavior therapy. However, the mechanisms behind the efficacy of behavior therapy have yet to be clarified by research.
The FDA has granted Orphan Drug Designation to Valbenazine.
Maternal tobacco smoking during pregnancy has previously been linked with numerous long-term neurodevelopmental abnormalities and child behavioral problems.